Top Biotech Performance Vs IBB Holdings


30-Jan-2018 07:19 AM



     The buyout of Juno Therapeutics (JUNO) and Bioverativ Inc (BIVV) has boosted the biotechnology sector.  With the tax reform, it only matter of time to see more acquisition down the road.. The iShares Nasdaq Biotechnology ETF (IBB:NASDAQ) and Spdr S&P Biotech Etf (XBI:NYSE) Year-To-Date up 10.99% and 14.33%, respectively. These are the current biotech best performance that helped the ETFs. Data as of Jan 29, 2018 close. 

  • Atara Biotherapeutics Inc (ATRA:NASDAQ)
  • CRISPR Therapeutics AG (CRSP:NASDAQ)
  • Global Blood Therapeutics Inc (GBT:NASDAQ)
  • Enanta Pharmaceuticals Inc (ENTA:NASDAQ)
  • Agio Pharmaceuticals Inc (AGIO:NASDAQ)

Here a look at IBB top holdings performance:

Contact us:

Twitter: @BiotechMoney18



Add Your Comment

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.